Aurora Cannabis reported 37% revenue growth in its most recent quarter. The company also posted a profit. The international medical cannabis market has played a key role in its recent rapid growth.

In combination with improved efficiency in the company's manufacturing operations and recent cost reduction initiatives, Aurora's medical cannabis gross margin increased by 600 basis points ...

EDMONTON, AB, February 6, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased to ...

Aurora Cannabis has a 12-month low of $2.84 and a 12-month high of $9.35. The business’s 50-day moving average is $4.35 and its 200 day moving average is $5.16.

Get Our Latest Research Report on Aurora Cannabis Aurora Cannabis Trading Down 3.7 % TSE:ACB opened at C$8.63 on Friday. The stock’s 50 day moving average price is C$6.08 and its 200 day moving ...

The term of the agreement is for three years with an option to extend and an estimated value of $27 million. EDMONTON — Aurora Cannabis signs a supply agreement with SNDL, a Canadian licensed ...

The year is a more than a month old, but Aurora Cannabis (NASDAQ: ACB) is already one of the hottest stocks to own in 2025. As of Feb. 11, the pot stock has soared more than 50% since the year ...

Largest Global Medical Cannabis Company Operating in Nationally Regulated Markets, Aurora Removes Concession Card Requirements to Access IndiMed Products in Australia Aurora Logo (CNW Group/Aurora ...

EDMONTON, AB, February 6, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased to announce a ...

These achievements, along with our strong cash position and debt-free cannabis business, underscore Aurora’s leadership in the global cannabis industry as we continue to set ourselves apart from ...

Shares of Aurora Cannabis (NASDAQ:ACB) added ~27% in the premarket on Wednesday after the Canadian marijuana producer reported better-than-expected revenue for Q3 fiscal 2025, thanks mainly to its ...